Skip to content
Medical Health Aged Care, Women

InMode Australia to Participate at the ‘Thriving Through Menopause’ Conference.

InMode Australia 3 mins read

InMode Australia to Participate at the 'Thriving Through Menopause' Symposium. Sydney, Australia – February 24th, at the State Library of NSW

InMode Australia to Participate at the 'Thriving Through Menopause' Symposium.
Sydney, Australia – February 24th, at the State Library of NSW. 

 

Sydney, Australia – February 21, 2025 – InMode Australia, a leader in medical aesthetic and wellness solutions, is proud to announce its participation at the upcoming ‘Thriving Through Menopause’ symposium, scheduled for February 24, 2025, at the State Library of NSW.

InMode will highlight the VTone technology, available on the EmpowerRF platform - an advanced, non-invasive treatment designed to address pelvic floor dysfunction and urinary incontinence in women. It utilises electrical muscle stimulation (EMS) and neuromuscular re-education to strengthen and rehabilitate weak pelvic floor muscles. This non-invasive and comfortable treatment is ideal for women experiencing stress urinary incontinence (SUI), mixed urinary incontinence (MUI), and overall pelvic floor weakness.

 

Addressing the Gap in Women's Health Education

This pioneering industry event is set to transform how menopause experts and industry professionals from diverse menopause specialties approach this pivotal stage in women’s lives. The aim is to embrace collaboration between doctors, nurses, and therapists to enhance patient outcomes as well as address the significant gap in understanding of a women’s holistic well-being during the transitional stages of menopause. The lack of uniform, readily available information on the changes that occur during menopause means that very often as an industry, there is a lack of confidence in initiating conversations with patients that would help better connect and offer reassurance and guidance where needed.

The Thriving Through Menopause Symposium (TTM) aims to change this, bringing together healthcare professionals to discuss alternative therapies that can positively impact women's well-being.


Dr. Aman Bhinder: Leading the Conversation on Women's Health

At the event, Dr. Aman Bhinder, a distinguished healthcare professional and founder of Clinic Auriq, will be a key speaker, sharing insights into the latest advancements in women's intimate health. With an impressive background that includes fellowships with the Royal Australian College of General Practitioners (RACGP), the Australasian College of Nutritional and Environmental Medicine (ACNEM), and the Australasian College of Aesthetic Medicine (ACAM), Dr. Bhinder is at the forefront of women’s wellness as well as integrative and aesthetic medicine.

As a Luminary for InMode, Dr. Bhinder is pioneering the use of InMode’s EmpowerRF Women’s Health platform, leveraging radiofrequency and EMS based technologies to provide safer, more effective, and innovative treatments for women. She has also conducted groundbreaking case studies on incorporating ASCE+ Exosomes by InMode for intimate care, offering new treatment options for women who have long suffered with common women’s health concerns.

InMode’s Commitment to Women’s Health and Wellness

InMode Australia maintains its unwavering support for women across the country, continuing our mission of providing life-changing, evidence-based technology to improve women’s health and wellness.
"Women's health deserves greater attention, research, and solutions that go beyond traditional methods," said Dr Aman Bhinder. "We are committed to supporting Australian women throughout their journey and advocating for continued innovation in this space." Dennis Cronje, Managing Director of InMode Australia.


Join the Conversation

The Thriving Through Menopause conference presents an opportunity for medical professionals, researchers, and industry leaders to come together and explore groundbreaking advancements in women’s health. InMode invites all attendees to engage in meaningful discussions on how technology and innovation can reshape the future of women’s health treatments. For more information visit: Thriving Through Menopause Symposium 

 


Key Facts:

InMode Australia maintains its unwavering support for women across the country, continuing our mission of providing life-changing, evidence-based technology to improve women’s health and wellness.


About us:

About InMode Australia

InMode is a leading global provider of innovative medical aesthetic technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology, light-based applications including IPL and laser, and EMS. InMode strives to enable new emerging non-surgical procedures as well as improving and complimenting existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories including plastic and cosmetic surgery, dermatology, optometry and ophthalmology, gynaecology and women’s health, and cosmetic clinics. For more information about InMode and its wide array of medical technologies, visit www.inmode.com.au 


Contact details:

Kate Boissett
Public Relations Manager - InMode ANZ
Phone: (02) 7209 5678
Mobile: 0422 734 621
Email:
[email protected]
Website:
www.inmode.com.au

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.